Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.
종목 코드 ADVB
회사Advanced Biomed Inc
CEO
웹사이트http://www.advanbiomed.com/
자주 묻는 질문
Advanced Biomed Inc(ADVB)의 현재 가격은 얼마인가요?
Advanced Biomed Inc(ADVB)의 현재 주가는 0.364입니다.
Advanced Biomed Inc의 종목 기호(Symbol)는 무엇인가요?
Advanced Biomed Inc의 종목 코드는 ADVB입니다.
Advanced Biomed Inc의 52주 최고가는 얼마인가요?
Advanced Biomed Inc의 52주 최고가는 4.100입니다.
Advanced Biomed Inc의 52주 최저가는 얼마인가요?
Advanced Biomed Inc의 52주 최저가는 0.310입니다.
Advanced Biomed Inc의 시가총액은 얼마인가요?
Advanced Biomed Inc의 시가총액은 7.88M입니다.
Advanced Biomed Inc의 순이익은 얼마인가요?
Advanced Biomed Inc의 순이익은 -3.26M입니다.
Advanced Biomed Inc(ADVB)의 현재 투자 등급은 매수, 보유, 매도 중 어떤가요?
애널리스트들에 따르면, Advanced Biomed Inc(ADVB)는 전반적인 평가에서 -- 등급을 받고 있으며, 목표 주가는 --입니다.